440例冠状动脉慢性完全闭塞病变伴心功能不全患者应用增强型体外反搏治疗的远期预后

doi:10.3969/j.issn.1006-6233.2021.11.021

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1367 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To explore the effect of Enhanced External Counterpulsation(EECP) on the cardiac function and prognosis of chronic total occlusion (CTO) patients with reduced ejection fraction. Methods: A total of 220 CTO inpatients with EECP therapy and a control group of 220 cases without EECP, which were consecutively enrolled from January 2015 to January 2019 in the division of cardiology in our hospital. The clinical data of the patients were collected and analysis. Results: There were not significant difference in smoking, hypertension and type 2 diabetes between two groups (all P>0.05). Compared to control group, left ventricular ejection fraction,6-minute walk test(6MWT) and B-type natriuretic peptide(BNP) were significantly higher in EECP group after therapy (all P<0.05). In addition, Point-biserial correlation analysis found that EECP was associated with 6MWT and BNP, which correlation coefficient were 0.454 and -0.523. Besides, the multivariate COX regression model showed that EECP was an independent protect prognostic risk factors of CTO with reduced ejection fraction and HR was 0.357(P<0.05). Conclusion: EECP therapy can improve exercise tolerance and cardiac function, which was an independent protect prognostic risk factors of CTO with reduced ejection fraction undergone PCI.

Key words： Enhanced external counterpulsation Chronic total occlusion Reduced ejection fraction Prognosis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHANG Haijuan
	SHI Xiucai
	MA Meihua
	et al

Cite this article:

ZHANG Haijuan,SHI Xiucai,MA Meihua, et al. Outcome of 440 Chronic Total Occlusion and Left Ventricular Dysfunction Patients with or Without Enhanced External Counterpulsation[J]. HeBei Med, 2021, 27(11): 1871-1877.

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2021.11.021 OR http://www.hbyxzzs.cn/EN/Y2021/V27/I11/1871

[1] Su YM,Pan M,Geng HH,et al.Outcomes after percutaneous coronary intervention and comparison among scoring systems in predicting procedural success in elderly patients ( 75 years) with chronic total occlusion[J].Coron Artery Dis,2019,30(7):481~487.
[2] Li B,Wang W,Mao B,et al.Long-term hemodynamic mechanism of enhanced external counterpulsation in the treatment of coronary heart disease:a geometric multiscale simulation[J].Med Biol Eng Comput,2019,57(11):2417~2433.
[3] Vemmou E,Alaswad K,Khatri JJ,et al.Patient radiation dose during chronic total occlusion percutaneous coronary intervention:insights from the PROGRESS-CTO registry.[J].Circ Cardiovasc Interv,2020,13(10):e009412.
[4] Mach F,Baigent C,Catapano AL,et al.2019 ESC/EAS Guidelines for the management of dyslipidaemias:lipid modification to reduce cardiovascular risk[J].Eur.Heart,2020,41(1):111~188.
[5] Zhu CP,Li TP,Wang X,et al.The relationship between apnoea hypopnoea index and Gensini score in patients with acute myocardial infarction undergoing emergency primary percutaneous coronary intervention[J].Thorac Dis,2017,9(8):2476~2483.
[6] Raza A,Steinberg K,Tartaglia J,et al.Enhanced external counterpulsation therapy:past,present,and future[J].Cardiol Rev,2017,25(2):59~67.
[7] Melin M,Montelius A,Ryden L,et al.Effects of enhanced external counterpulsation on skeletal muscle gene expression in patients with severe heart failure[J].Clin Physiol Funct Imaging,2018,38(1):118~127.
[8] 黄鑫,赵佳佳,樊俊雅,等.增强型体外反搏治疗老年射血分数保留型心力衰竭的临床疗效[J].实用医学杂志,2019,35(23):3633~3637.
[9] Xiong J,Zhang W,Wei H,et al.Enhanced external counterpulsation improves cardiac function in beagles after cardiopulmonary resuscitation[J].Braz Med Biol Res,2020,53(1):e9136.
[10] 刘苗苗,樊俊雅,刘贞,等.增强型体外反搏在冠心病合并心功能不全患者心脏康复训练治疗中的应用价值研究[J].中国全科医学,2020,23(18):2270~2274.